- Email: [email protected]
5453354 Method for improving sperm motility
PATENT ABSTRACTS
Hydro-activated and/or oxygen activated aqueous, enzymatic, antimicrobial dentifrices are stabilized against enzymatic activation prior to oral application of the dentifrice by incorporating a thickener into the dentifrice formulation so as to provide the formulation with an enzyme immobilizing viscosity which inhibits enzymatic action during processing and in the dentifrice package. An illustrative, thickened, enzymatic dentifrice with this enhancement contains glucose oxidase, glucose, lactoperoxidase and potassium thiocyanate together with carboxymethylcellulose in an amount to provide the dentifrice with a viscosity of at least about 800 centipoises.
5453354 METHOD FOR IMPROVING SPERM MOTILITY AkerlofEv; Pousette Ake Huddinge, SWEDEN assigned to Akeriof Ev; Pousette Ake: Applied Research Systems ARS Holding N The present invention relates to a macromolecule of proteinaceous nature which activates sperm motility, a process for the preparation thereof by purification of the macromolecule from extracellular fluids, pharmaceutical preparations containing the macromolecule and antibodies directed against determinants specific to the macromolecule and the use thereof as a method to assay the potential fertility of sperm.
5453355 OLIGONUCLEOTIDES AND METHODS FOR THE DETECTION OF NEISSERIA GONORRHOEAE Birkenmeyer Larry; Ching Shanfun; Ohhashi Yoshihiro; Winkler Janet K Chicago, IL, UNITED STATES assigned to Abbott Laboratories The present invention relates to oligonucleotide probes and primers useful in detecting Neisseria gonorrhoeae e.g. by the polymerase chain reaction. The present invention is also directed to
535
methods for detecting Neisseria gonorrhoeae by the polymerase chain reaction. The probes and primers are specific for the pilin gene.
5453357 PLURIPOTENTIAL EMBRYONIC STEM CELLS AND METHODS OF MAKING SAME Hogan Brigid L M Brentwood, TN, UNITED STATES assigned to Vanderbilt University The present invention provides a non-mouse pluripotential embryonic stem cell which can: (a) be maintained on feeder layers for at least 20 passages; and (b) give rise to embryoid bodies and multiple differentiated cell phenotypes in monolayer culture. The invention further provides a method of making a pluripotential embryonic stem cell comprising administering a growth enhancing amount of basic fibroblast growth factor, leukemia inhibitory factor, membrane associated steel factor, and soluble steel factor to primordial germ cells under cell growth conditions, thereby making a pluripotential embryonic stem cell.
5453369 ENZYME FOR PRODUCING NOVEL CYCLOOISOMALTOOLIGOSAC CHAR[DES Oguma Tetsuy; Horiuchi Tatsu; Tobe Koichiro Noda, JAPAN assigned to Kikkoman Corporation; Noda Institute for Scientific Resear The present invention relates to a novel cycloisomaltooligosaccharide selected from the group consisting of novel cycloisomaltoheptaose having a cyclic structure composed of 7 glucose residues in alpha-l,6 linkage, novel cycloisomaltooctaose having a cyclic structure composed of 8 glucose residues in alpha-l,6 linkage and novel cycloisomaltononaose having a cyclic structure composed of 9 glucose residues in alpha-l,6 linkage, novel cycloisomaltooligosaccharide synthase forming said oligosaccharides from dextran, and a
Hydro-activated and/or oxygen activated aqueous, enzymatic, antimicrobial dentifrices are stabilized against enzymatic activation prior to oral application of the dentifrice by incorporating a thickener into the dentifrice formulation so as to provide the formulation with an enzyme immobilizing viscosity which inhibits enzymatic action during processing and in the dentifrice package. An illustrative, thickened, enzymatic dentifrice with this enhancement contains glucose oxidase, glucose, lactoperoxidase and potassium thiocyanate together with carboxymethylcellulose in an amount to provide the dentifrice with a viscosity of at least about 800 centipoises.
5453354 METHOD FOR IMPROVING SPERM MOTILITY AkerlofEv; Pousette Ake Huddinge, SWEDEN assigned to Akeriof Ev; Pousette Ake: Applied Research Systems ARS Holding N The present invention relates to a macromolecule of proteinaceous nature which activates sperm motility, a process for the preparation thereof by purification of the macromolecule from extracellular fluids, pharmaceutical preparations containing the macromolecule and antibodies directed against determinants specific to the macromolecule and the use thereof as a method to assay the potential fertility of sperm.
5453355 OLIGONUCLEOTIDES AND METHODS FOR THE DETECTION OF NEISSERIA GONORRHOEAE Birkenmeyer Larry; Ching Shanfun; Ohhashi Yoshihiro; Winkler Janet K Chicago, IL, UNITED STATES assigned to Abbott Laboratories The present invention relates to oligonucleotide probes and primers useful in detecting Neisseria gonorrhoeae e.g. by the polymerase chain reaction. The present invention is also directed to
535
methods for detecting Neisseria gonorrhoeae by the polymerase chain reaction. The probes and primers are specific for the pilin gene.
5453357 PLURIPOTENTIAL EMBRYONIC STEM CELLS AND METHODS OF MAKING SAME Hogan Brigid L M Brentwood, TN, UNITED STATES assigned to Vanderbilt University The present invention provides a non-mouse pluripotential embryonic stem cell which can: (a) be maintained on feeder layers for at least 20 passages; and (b) give rise to embryoid bodies and multiple differentiated cell phenotypes in monolayer culture. The invention further provides a method of making a pluripotential embryonic stem cell comprising administering a growth enhancing amount of basic fibroblast growth factor, leukemia inhibitory factor, membrane associated steel factor, and soluble steel factor to primordial germ cells under cell growth conditions, thereby making a pluripotential embryonic stem cell.
5453369 ENZYME FOR PRODUCING NOVEL CYCLOOISOMALTOOLIGOSAC CHAR[DES Oguma Tetsuy; Horiuchi Tatsu; Tobe Koichiro Noda, JAPAN assigned to Kikkoman Corporation; Noda Institute for Scientific Resear The present invention relates to a novel cycloisomaltooligosaccharide selected from the group consisting of novel cycloisomaltoheptaose having a cyclic structure composed of 7 glucose residues in alpha-l,6 linkage, novel cycloisomaltooctaose having a cyclic structure composed of 8 glucose residues in alpha-l,6 linkage and novel cycloisomaltononaose having a cyclic structure composed of 9 glucose residues in alpha-l,6 linkage, novel cycloisomaltooligosaccharide synthase forming said oligosaccharides from dextran, and a